[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100094359":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":25,"centralContacts":29,"locations":35,"responsibleParty":55,"collaborators":10,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":10,"eligibilityCriteria":63,"healthyVolunteers":59,"sex":64,"minAge":10,"maxAge":10,"enrollmentInfo":65,"targetDuration":10,"studyType":68,"phases":10,"briefSummary":69,"conditions":70,"keywords":10,"overallStatus":38,"whyStopped":10,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":86},{"fullName":5,"class":6},"M.D. Anderson Cancer Center","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Observational (electronic health record review)",null,"Patients' medical records are reviewed for retrospective and prospective data collection. Patients may also have residual tissue samples collected and stored.",[13,14],"Procedure: Biospecimen Collection","Other: Electronic Health Record Review",[16,21],{"type":17,"name":18,"description":19,"armGroupLabels":20,"otherNames":10},"PROCEDURE","Biospecimen Collection","Patients' residual tissue samples are collected",[9],{"type":6,"name":22,"description":23,"armGroupLabels":24,"otherNames":10},"Electronic Health Record Review","Medical records are reviewed",[9],[26],{"name":27,"affiliation":5,"role":28},"David M Gershenson","PRINCIPAL_INVESTIGATOR",[30],{"name":31,"role":32,"phone":33,"phoneExt":10,"email":34},"Lisa Nathan","CONTACT","713-745-3837","lcnathan@mdanderson.org",[36],{"facility":37,"status":38,"city":39,"state":40,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"M D Anderson Cancer Center","RECRUITING","Houston","Texas","77030","United States","US",{"type":45,"coordinates":46},"Point",[47,48],-95.36327,29.76328,{"lat":48,"lon":47},[51,54],{"name":52,"role":32,"phone":53,"phoneExt":10,"email":10},"David M. Gershenson","713-563-4535",{"name":52,"role":28,"phone":10,"phoneExt":10,"email":10},{"type":56,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100094359","data-collection-for-patients-with-low-grade-ovarian-or-peritoneal-tumors-100094359",false,"NCT00488878","Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors","Data Collection for Patients With Low Grade Ovarian Carcinoma","Inclusion Criteria:\n\n* Patients whose disease progressed to a higher-grade carcinoma since the time of original diagnosis:\n\n  * Ovarian tumor of low malignant potential\n  * Low-grade serous carcinoma of the ovary\n  * Primary peritoneal tumor of low malignant potential\n  * Low-grade serous carcinoma of the peritoneum\n  * Psammocarcinoma","FEMALE",{"count":66,"type":67},2000,"ESTIMATED","OBSERVATIONAL","This study collects information to maintain a database on patients with low-grade ovarian or peritoneal tumors. Collecting information about the type of cancer and treatment, as well as details about follow-up care, may help researchers learn and better understand these tumor types and help develop better treatments for them.",[71,72,73,74,75,76],"Low Grade Ovarian Serous Adenocarcinoma","Malignant Ovarian Neoplasm","Ovarian Carcinoma","Primary Peritoneal Carcinoma","Primary Peritoneal Low Grade Serous Adenocarcinoma","Psammocarcinoma","2026-02-11",{"date":79,"type":80},"2026-02-13","ACTUAL",{"date":82,"type":80},"2006-05-19",{"date":84,"type":67},"2035-05-01",{"name":5,"class":6},1]